Ambition and precision: How the EU’s pharma package can still be improved

https://www.eurordis.org/how-pharma-package-can-be-improved/ Pharma package Trilogue negotiations between the Council of the EU and the European Parliament on the pharmaceutical reforms resumed last week, with patient representation on European Medicines Agency (EMA) committees on the agenda. As the Council’s position risks weakening patient involvement at the EMA, EURORDIS and the European Patients' Forum (EPF) are reaffirming the community’s stance and urging patient organisations to advocate for protected participation using the EURORDIS-EPF Keep Patients Voting campaign toolkit. Keep Patients Voting: Campaign Toolkit https://www.eurordis.org/publications/keep-patients-voting-campaign-toolkit/ https://www.eu-patient.eu/